Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
12/28/1995 | CA2205203A1 Ctcf |
12/28/1995 | CA2193682A1 Methods and compositions including a 13 kd b. burgdorferi protein |
12/28/1995 | CA2193625A1 Novel bacillus thuringiensis strains active against lepidopteran and coleopteran pests |
12/28/1995 | CA2193526A1 Polypeptides with interleukin 8 receptor 1 (il8r1) binding domains |
12/28/1995 | CA2193255A1 Plant genes for sensitivity to ethylene and pathogens |
12/28/1995 | CA2193206A1 Contraceptive vaccine |
12/28/1995 | CA2193205A1 High-affinity melatonin receptors and uses thereof |
12/28/1995 | CA2193123A1 Plant virus resistance gene and methods |
12/28/1995 | CA2192971A1 Expression control polynucleotides derived from spliceosomal protein gene promoters |
12/28/1995 | CA2192943A1 N-terminally extended proteins expressed in yeast |
12/28/1995 | CA2169739A1 Glucan elicitor receptor and dna coding for the same |
12/28/1995 | CA2126787A1 Agents for the prevention and treatment of human alzheimer's disease |
12/27/1995 | EP0688874A2 Nucleic acid fragments and diagnostic reagents derived from the genome of HHV6/SIE and diagnostic procedures for HHV6 infections |
12/27/1995 | EP0688869A1 Novel osteoinductive compositions |
12/27/1995 | EP0688868A1 Genetic detoxification of pertussis toxin |
12/27/1995 | EP0688790A1 Peptide fragment specific for feline immunodeficiency virus (FIV), and its use as a diagnostic reagent |
12/27/1995 | EP0688789A1 Lipopeptid-derivatives, process for their preparation and their use |
12/27/1995 | EP0688788A1 Boronic acid peptide derivatives having protease inhibiting activity, process for preparation thereof and pharmaceutical compositions comprising them |
12/27/1995 | EP0688432A1 Kit for diagnosing an hcg- or hcg fragment-secreting cancer and immunotherapeutical means therefor |
12/27/1995 | EP0688364A1 Genetically engineered enzymes and their conjugates for diagnostic assays |
12/27/1995 | EP0688363A1 Method of controlling insects in plants |
12/27/1995 | EP0688362A1 Cloning and recombinant production of vespid venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
12/27/1995 | EP0688361A1 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
12/27/1995 | EP0688360A1 Bone stimulating factor |
12/27/1995 | EP0688338A1 T cell epitopes of ryegrass pollen allergen |
12/27/1995 | EP0688335A1 Purification of human interleukin-10 |
12/27/1995 | EP0688334A1 Oligodendroglial trophic factor and methods of use thereof |
12/27/1995 | EP0688327A1 Analogs for specific oligosaccharide-protein interactions and uses therefor |
12/27/1995 | EP0688316A1 Coupling method using selective amination of maleimide |
12/27/1995 | EP0688227A1 Production of human papillomavirus capsid protein and virus-like particles |
12/27/1995 | EP0688225A1 Methods and compositions for the inhibition of complement activation |
12/27/1995 | EP0688224A1 A mutant protein and methods and materials for making and using it |
12/27/1995 | EP0605433B1 Immunoassay for the simultaneous detection of hiv-1, hiv-2, htlv-i and htlv-ii antibodies |
12/27/1995 | EP0580694A4 Production of phosphopeptides from casein |
12/27/1995 | EP0573491A4 Mineralized collagen |
12/27/1995 | EP0550650B1 Antagonists of human gamma interferon |
12/27/1995 | EP0419621B1 Process for the specific replacement of a copy of a gene present in the receiver genome via the integration of a gene |
12/27/1995 | EP0418230B1 Method for potentiating and inhibiting insulin-like growth factor activity |
12/27/1995 | EP0379549B1 Endotoxin binding protein and uses thereof |
12/27/1995 | EP0268663B1 Phosphopeptides |
12/27/1995 | CN1114112A Bacteriocins from streptococcus thermophilus |
12/26/1995 | US5478925 Peptides which block the binding of Tumor Necrosis Factor to its receptors |
12/26/1995 | US5478923 Class of low calorie protein sweeteners |
12/26/1995 | US5478810 Peptide amides, processes for the preparation thereof and agents containing these as fibrin/thrombin clotting inhibitors |
12/26/1995 | US5478807 Increases rate of stimulus provided by subsidiary pacemakers |
12/26/1995 | US5478806 Enhancement of antitumor therapy with hemoglobin-based conjugates |
12/26/1995 | US5478805 Fractionation of polyalkylene oxide-conjugated hemoglobin solutions |
12/26/1995 | US5478746 cDNA encoding attenuated cell culture adapted hepatitis A virus genome |
12/26/1995 | US5478741 Antibodies to the HRPII protein of plasmodium falciparum |
12/26/1995 | US5478740 Hybridomas and monoclonal antibodies which specifically bind human basic fibroblast growth factor |
12/26/1995 | US5478730 Chemical reactor with barrier for maintaining high molecular weight compounds and replacement of low molecular weight compounds |
12/26/1995 | US5478727 Methods and compositions for the preparation and use of a herpes protease |
12/26/1995 | US5478726 Mixing sample containing human lymphocytes with stimulant culture containing antigen-producing cells and peptide antigen then maintaining culture until immune cells indicate stimulation, if present, kits for medical diagnosis |
12/26/1995 | US5478558 Administering composition free of serum amyloid P, thrombin activity, infectious agents, antibodies |
12/26/1995 | US5478369 Nucleotide sequences mediating male fertility and method of using same |
12/26/1995 | CA1337841C Antibiotic a 42867 derivative |
12/26/1995 | CA1337839C Synthesis of peptide amides by means of a solid phase method using acid-labile anchoring groups |
12/26/1995 | CA1337838C Aglycons of a/16686 antibiotics |
12/26/1995 | CA1337801C Immobilized artificial membranes |
12/26/1995 | CA1337800C Monoclonal antibody recognizing alpha 2 --> 3 bonds |
12/26/1995 | CA1337799C Htlv-i peptide antigen and assay |
12/24/1995 | CA2152426A1 Crucifer aft proteins and uses thereof |
12/23/1995 | CA2152205A1 Boronic acid peptidic derivatives; process for preparing the same and pharmaceutical compositions containing them |
12/21/1995 | WO1995034817A1 Positive and positive/negative cell selection mediated by peptide release |
12/21/1995 | WO1995034686A1 Isolation and diagnosis of coronaviruses |
12/21/1995 | WO1995034684A1 Recombinant virus and related method of quantitating same |
12/21/1995 | WO1995034682A1 A new and distinctive dna sequence of e. coli 0157:h7 and its use for the rapid, sensitive and specific detection of 0157:h7 and other enterohemorrhagic e. coli |
12/21/1995 | WO1995034680A1 Method to identify tumor suppressor genes |
12/21/1995 | WO1995034671A1 Complementary adenoviral vector systems and cell lines |
12/21/1995 | WO1995034670A2 Recombinant aav genome encoding immunodeficiency virus protein |
12/21/1995 | WO1995034669A2 Retroviral gene therapy vectors and therapeutic methods based thereon |
12/21/1995 | WO1995034668A2 The cytoplasmic inhibition of gene expression |
12/21/1995 | WO1995034666A1 Synthetic leader peptide sequences |
12/21/1995 | WO1995034664A1 Method of detecting ligand interactions |
12/21/1995 | WO1995034661A1 Fas associated proteins |
12/21/1995 | WO1995034656A1 Novel bacillus thuringiensis genes coding toxins active against lepidopteran pests |
12/21/1995 | WO1995034655A2 Surface protein of staphylococcus aureus |
12/21/1995 | WO1995034654A1 Dna molecules which code for a plastid 2-oxoglutarate/malate translocator |
12/21/1995 | WO1995034653A1 Epil/placentine |
12/21/1995 | WO1995034651A2 Corticotropin-releasing factor2 receptors |
12/21/1995 | WO1995034650A2 Mn gene and protein |
12/21/1995 | WO1995034649A2 Polycystic kidney disease 1 gene and uses thereof |
12/21/1995 | WO1995034648A1 A method for displaying proteins |
12/21/1995 | WO1995034646A1 Novel cell systems having specific interaction of peptide binding pairs |
12/21/1995 | WO1995034641A1 Structural models for cytoplasmic domains of transmembrane receptors |
12/21/1995 | WO1995034640A1 A novel neuronal-neonatal gene: neuronatin |
12/21/1995 | WO1995034639A1 Novel retroviral envelope and ltr and retroviral vector particles including such envelope and/or ltr |
12/21/1995 | WO1995034634A2 Use of anthocyanin genes to maintain male sterile plants |
12/21/1995 | WO1995034580A1 Isolated nucleic acid encoding retinol dehydrogenase |
12/21/1995 | WO1995034579A1 Recombinant molecules, proteins/polypeptides, host systems and diagnostic and therapeutic methods for atopy |
12/21/1995 | WO1995034578A1 Recombinant allergen, fragments thereof, corresponding recombinant dna molecules, vectors and hosts containing the dna molecules, diagnostic and therapeutic uses of said allergens and fragments |
12/21/1995 | WO1995034574A1 Rapid and sensitive detection of antibiotic-resistant mycobacteria using oligonucleotide probes specific for ribosomal rna precursors |
12/21/1995 | WO1995034573A1 Identification of polycystic kidney disease gene, diagnostics and treatment |
12/21/1995 | WO1995034572A1 THE PRODUCTION OF HEMOGLOBIN HAVING A δ-LIKE GLOBIN |
12/21/1995 | WO1995034326A1 Pegylation reagents and compounds formed therewith |
12/21/1995 | WO1995034322A1 Method of purifying necrotoxin produced by bordetella and toxoid |
12/21/1995 | WO1995034321A1 Immune modulation with class ii alpha-chain fragments |
12/21/1995 | WO1995034320A2 Methods for inhibiting antigen specific t cell responses |
12/21/1995 | WO1995034317A1 Growth factor preparation, its production and use |
12/21/1995 | WO1995034316A1 Suppression of tumor cell growth by syndecan-1 ectodomain |